Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06711562Recruiting
Personalized Dosing for Bone and Joint Infection
This study aims to customize anti-infection medication doses for people with bone or joint infections. The goal is to make treatment more effective and reduce side effects.
JinanAges Any age - NCT06717581Recruiting
Drug interaction study for older people with HIV
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
BolognaAges 18 years+ - NCT07582887Recruiting
Genetic Testing to Predict Side Effects from Breast Cancer Antibody Drugs
This study examines how genetic differences affect how your body handles three newer breast cancer medications (Sacituzumab Govitecan, Trastuzumab Deruxtecan, or Datopotamab Deruxtecan). A blood test will check your UGT1A1 gene to help doctors predict which side effects you might experience and adjust your treatment accordingly.
Granada, GranadaAges 18 years+ - NCT06440915Recruiting
Isavuconazole drug monitoring study for children with fungal infections
This study monitors how the antifungal drug isavuconazole works in children's bodies. It aims to find the right dose for treating serious fungal infections.
ShanghaiAges Up to 18 years - NCT07557810Recruiting
Thermal Ablation Plus Drugs for Overactive Thyroid
This trial tests combining heat treatment of the thyroid gland with antithyroid medications to treat primary hyperthyroidism (an overactive thyroid). It may help patients who haven't responded well to standard drugs, had side effects, or want faster symptom relief.
BeijingAges Up to 80 years - NCT03671629Recruiting
Pharmacist visits to help prevent hospital readmissions
This trial tests whether adding regular check-ins with a clinical pharmacist can reduce repeat hospital visits after an urgent hospital stay for older adults. It may help by reviewing medicines and supporting safer use at home.
UmeåAges 75 years+ - NCT07550816RecruitingPhase 1
Safety study of ZT002 injection in overweight adults
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
Chengdu, SichuanAges 18–45 - NCT07542938Recruiting
Drug-coated balloon for narrowed brain arteries
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
Beijing, Beijing MunicipalityAges 18–80 - NCT07541131Enrolling by invitation
Reducing HIV stigma to improve treatment access for drug users
This study tests whether reducing stigma and discrimination against people who use drugs can help more people access HIV treatment and prevention. You would participate in peer-led group sessions and surveys over 18 months to help researchers understand how stigma affects treatment access in Bishkek.
BishkekAges 18 years+ - NCT07525427RecruitingPhase 2
New Tuberculosis Drug Study for Drug-Sensitive TB
This study tests a new tuberculosis drug called TBD09 combined with other TB medicines in people with newly diagnosed, drug-sensitive TB. The goal is to see if this combination works well and is safe.
Durban, BluffAges 18–65 - NCT06753981Recruiting
Triple drug therapy for new PAH patients
This trial tests whether a combination of three medications works well and is safe for people newly diagnosed with pulmonary arterial hypertension (PAH) that is not low-risk. It aims to see if starting with triple therapy early can improve outcomes.
Jinan, ShandongAges 18–80 - NCT07516548Recruiting
Long-acting HIV prevention and birth control study
This research studies how two types of long-acting birth control (a shot called cabotegravir and an implant) work in your body after pregnancy, and how they interact with HIV prevention or treatment. The study helps doctors understand the best doses and timing for women like you.
Bontleng, GaboroneAges 18 years+ - NCT07518238Enrolling by invitationPhase 2
Pain Relief Methods for Abdominal Wall Surgery
This study compares two different pain-relief injection techniques (BDE and Exparel) given during abdominal wall reconstruction surgery to see which works better at reducing pain and opioid use after surgery. You would receive one of these injections as part of your anesthesia care.
Dallas, TexasAges 18 years+ - NCT06422845Recruiting
Drug-coated balloon for dialysis fistula narrowing
This trial tests a special balloon that releases medication to help keep your dialysis fistula (the blood vessel used for treatment) open longer if it has narrowed. It may be a good option if you have a blockage in the vein side of your fistula that causes problems during dialysis.
Hefei, AnhuiAges 18–80 - NCT07499791RecruitingPhase 2
Absorbable stent for recurrent tear duct infection
This trial tests a new type of dissolvable stent that slowly releases medicine to treat chronic tear duct infections that have come back after previous surgery. It may help people who need another treatment option.
Beijing, Beijing MunicipalityAges 18–65 - NCT07493226Recruiting
NSAIDs for Frozen Shoulder Pain Study
This study tests different types of nonsteroidal anti-inflammatory drugs (NSAIDs) to see which works best for people with frozen shoulder. It may help you if you have ongoing shoulder pain and stiffness without other shoulder injuries.
Konya, SelçukluAges 18–75 - NCT07491107Recruiting
Registry of a new drug-eluting stent for complex coronary lesions
This study tracks how well a new drug-eluting stent (a small mesh tube that keeps arteries open and releases medicine to prevent re-narrowing) performs in people with complex coronary artery disease. It aims to see if the stent is safe and effective in real-world patients with long, calcified, or multiple blocked arteries.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06507345Recruiting
Non-opioid pain relief after breast surgery
This trial tests whether non-opioid pain medicines can effectively control pain after mastectomy or lumpectomy, allowing you to go home the same day without needing strong opioids.
Montreal, QuebecAges 18 years+ - NCT07481539RecruitingPhase 2
Antibiotic shot for severe infections vs. IV method
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
Udine, Italia/UDAges 18 years+ - NCT07480785Recruiting
Nerve stimulation plus 3 anti-nausea drugs for surgery nausea
This trial tests whether combining a gentle electrical nerve stimulation technique (called TEAS) with three standard anti-nausea medicines can better prevent nausea and vomiting after laparoscopic surgery in women at high risk. If you qualify, you would receive the stimulation plus the medicines, or the medicines alone, to see which works best.
Hangzhou, ZhejiangAges 18–65 - NCT06782984Recruiting
Testing drugs on your glioblastoma tumor model
This trial uses a lab-grown model of your tumor (called an organoid) to test whether different drugs might work against it. The goal is to find the best treatment for your specific glioblastoma.
Daejeon, Chungcheongnam-doAges Any age - NCT07466784Recruiting
Opioid use registry for emergency patients
This study is for people who come to the emergency department because of an opioid overdose, withdrawal, or related problem. It will collect information about patients' experiences to help improve care and support for opioid use.
Vancouver, British ColumbiaAges Any age - NCT07454291RecruitingPhase 1
How taladegib works in healthy volunteers
This trial is for healthy volunteers to see how the study drug taladegib (ENV-101) interacts with other medicines in the body. It will help researchers understand how the drug is absorbed and processed, which is important for future studies in patients.
Brisbane, QueenslandAges 26–65 - NCT07445334Recruiting
Catheter ablation vs. medications for frequent extra heartbeats
This study compares two ways to treat premature ventricular contractions (extra heartbeats that can cause symptoms). One approach is a catheter ablation (a procedure that destroys the tissue causing the extra beats), and the other is using anti-arrhythmic drugs (medications to control the rhythm). If you have frequent PVCs and a healthy heart, this trial could help you find the best treatment.
Westmead, New South WalesAges 18 years+
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.